Small molecule inhibitors restore normal BRAF structure, offering insight into cancer-causing mutations
Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural changes that enable the BRAF protein to escape control and mimic its activation, giving it strong potential to cause cancer.